Sedation In ICU Setting Market - Global Outlook and Forecast 2024-2031

Report ID: 1377019 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story

Sedation is the reduction of irritability or agitation by administration of sedative drugs, generally to facilitate a medical procedure or diagnostic procedure.
This report contains market size and forecasts of Sedation In ICU Setting in Global, including the following market information:
Global Sedation In ICU Setting Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sedation In ICU Setting market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Propofol Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sedation In ICU Setting include AstraZeneca, GlaxoSmithKline, Mylan, Fresenius, Teva, B. Braun Holding and Aspen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sedation In ICU Setting companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sedation In ICU Setting Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sedation In ICU Setting Market Segment Percentages, by Type, 2021 (%)
Propofol
Dexmedetomidine
Remifentanil
Others
Global Sedation In ICU Setting Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sedation In ICU Setting Market Segment Percentages, by Application, 2021 (%)
Neonatal Intensive Care Unit
Child Intensive Care Unit
Adult Intensive Care Unit
Global Sedation In ICU Setting Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sedation In ICU Setting Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sedation In ICU Setting revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sedation In ICU Setting revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
GlaxoSmithKline
Mylan
Fresenius
Teva
B. Braun Holding
Aspen

Frequently Asked Questions
Sedation In ICU Setting Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sedation In ICU Setting Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sedation In ICU Setting Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports